Skip to content
2000
Volume 17, Issue 1
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Background: Phencyclidine (PCP) as well as the analogues has indicated several pharmacological behaviors like analgesic, anticonvulsant, antianxiety, antidepressant depending on the dose and species examined. They interact with some neurotransmitter systems in the central nervous system like particular affinity for PCP sites in NMDA receptors or dopamine uptake blocking or both. Objective: Due to analgesic properties of aminobenzothiazoles family, piperidine ring of PCP was replaced with electron-donating and electron-withdrawing substituted aminobenzothiazoles (1-4) for obtaining new analogues (II-V) with more analgesic activities. Methods: Synthesis of new compounds (II-V) and measuring the acute and chronic pain properties of them were carried out through applying tail immersion tests on mice and the outcomes compared with control & PCP groups at dosage of 10 mg/kg. Results: III & V with substituted methoxy and methyl-aminobenzothiazoles indicated better activity to lessen acute and chronic (thermal and chemical) pains compared with unsubstituted & phencyclidine animal groups. Conclusion: Methoxy and methyl-aminobenzothiazole derivatives” of phencyclidine revealed more analgesic activities compared with other groups which may concern to close affinity for DA uptake blocking as well as NMDA receptors in this family.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557516666160428112532
2017-01-01
2024-11-19
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557516666160428112532
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test